Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of US ...

Long-term thinking guides everything we do to sustain Microsoft's success and create value for shareholders, now and for the future. Strong corporate governance, informed by active engagement with ...

Aurobindo Pharma Ltd share price was up by ... Please try again later. DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet ...

Aurobindo Pharma Limited announced today that its subsidiary Eugia Pharma Specialities Limited has received US Food & Drug Administration (USFDA) final approval to manufacture and market Pazopanib ...

They make strategic decisions and ensure the company adheres to legal and ethical standards.,Directors play a pivotal role in corporate g... "Lorem ipsum dolor sit amet, consectetur adipiscing elit, ...

(PTI) An official in the state medical and health department said the Aurobindo Pharma group recently wrote to the state government agreeing to withdraw its ambulance services on the ground that ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are ...

Stocks to buy today: Stocks that were in focus include names like SAIL, which rose 4% and Aurobindo Pharma, which gained 1% and HPCL, whose shares declined nearly 1% on Monday.

Aurobindo Pharma Ltd.'s wholly-owned subsidiary, Eugia Pharma Specialities Ltd., has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Pazopanib ...

Aurobindo Pharma's subsidiary, Apitoria Pharma, received two procedural observations from the USFDA after an inspection of its Telangana API manufacturing facility. The company stated it will ...